Green Alpha Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Green Alpha Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-24,575	Closed	-$677K	–	128
2021 Q2	$677K	Buy	+24,575	New	+$483K	0.46%	105

Green Alpha Advisors's TBIO Position: Q3 2021 in Review

Green Alpha Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 24,575 shares — an estimated $677K sold.

Green Alpha Advisors first reported a position in TBIO in Q2 2021 and held it in 1 quarter. The position peaked at $677K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Green Alpha Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Green Alpha Advisors sold 24,575 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $677K.
Green Alpha Advisors first reported a position in Translate Bio, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
Green Alpha Advisors's Translate Bio, Inc. Common Stock position peaked at $677K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Green Alpha Advisors's 13F filing for Q3 2021, filed 12 Oct 2021.